Cargando…

The Role of N(6)-Methyladenosine (m(6)A) Methylation Modifications in Hematological Malignancies

SIMPLE SUMMARY: Recently, despite the common application of various novel therapies (e.g., immunotherapy and stem cell transplantation) in hematologic tumors, hematologic malignancies remain suboptimal and have a worse prognosis due to the lack of donors and their high heterogeneity. Among them, epi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yan, Peng, Hongling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774242/
https://www.ncbi.nlm.nih.gov/pubmed/35053496
http://dx.doi.org/10.3390/cancers14020332